Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018179601> ?p ?o ?g. }
- W2018179601 endingPage "894" @default.
- W2018179601 startingPage "888" @default.
- W2018179601 abstract "OBJECTIVE: We have undertaken a study to assess the efficiency of serological tests in the diagnosis of celiac disease (CD) during the period January 1, 1994 to January 7, 1997. Our aim was to evaluate the sensitivity of IgA antiendomysium (EMA) and IgA antigliadin (AGA) with regard to the degree of histological abnormality in biopsy specimens of small intestine in untreated celiac disease patients and first-degree relatives. METHODS: The study population comprised 101 cases: 85 untreated celiac patients and 16 first-degree relatives with a mean age of 42 yr (range, 2–76 yrs). Sixteen of 85 were excluded from study because they did not satisfy the study or diagnostic criteria of CD. EMA and AGA have been compared with the degree of villous atrophy (VA) in 69 celiac patients and 16 relatives according to the Marsh criteria of 1992. We divided the Marsh III histology into three subgroups as follows: Marsh IIIa (partial VA), Marsh IIIb (subtotal VA), and Marsh IIIc (total villous atrophy). RESULTS: The specificity and positive predictive value of EMA for CD was excellent, because all EMA-positive patients (n = 42) were diagnosed with CD. The sensitivity of EMA, however, differed between CD subgroups; in patients with total VA, the sensitivity of EMA was 100% (17/17). However, in patients with partial VA (Marsh IIIa), the sensitivity of EMA was disappointing, only 9/29 (31%). Three of 72 celiacs with Marsh IIIb and Marsh IIIc had IgA deficiency and were excluded from the study. Elevated AGA has been detected in the sera of 39 of 69 (62%) patients. A combination of EMA and AGA tests showed a sensitivity of 76% (53/69). None of 16 first-degree relatives with Marsh I-II had positive EMA. CONCLUSIONS: Interpretation of negative serology needs great awareness. Although EMA sensitivity in total villous atrophy is excellent, in partial villous atrophy the sensitivity of EMA appears to be disappointing. Our experience shows that EMA and AGA have only limited value in screening programs for CD." @default.
- W2018179601 created "2016-06-24" @default.
- W2018179601 creator A5010012768 @default.
- W2018179601 creator A5029249023 @default.
- W2018179601 creator A5040611576 @default.
- W2018179601 creator A5072029105 @default.
- W2018179601 creator A5072771695 @default.
- W2018179601 creator A5075116572 @default.
- W2018179601 date "1999-04-01" @default.
- W2018179601 modified "2023-10-01" @default.
- W2018179601 title "Sensitivity of Antiendomysium and Antigliadin Antibodies in Untreated Celiac Disease: Disappointing in Clinical Practice" @default.
- W2018179601 cites W1965090187 @default.
- W2018179601 cites W1966486826 @default.
- W2018179601 cites W1968437724 @default.
- W2018179601 cites W1971235864 @default.
- W2018179601 cites W2000697458 @default.
- W2018179601 cites W2008830449 @default.
- W2018179601 cites W2011464592 @default.
- W2018179601 cites W2023111151 @default.
- W2018179601 cites W2030630876 @default.
- W2018179601 cites W2040308442 @default.
- W2018179601 cites W2046162307 @default.
- W2018179601 cites W2052079115 @default.
- W2018179601 cites W2068280904 @default.
- W2018179601 cites W2091518539 @default.
- W2018179601 cites W2103667148 @default.
- W2018179601 cites W2106951285 @default.
- W2018179601 cites W2113776156 @default.
- W2018179601 cites W2121138442 @default.
- W2018179601 cites W2131132948 @default.
- W2018179601 cites W2151550314 @default.
- W2018179601 cites W2315672113 @default.
- W2018179601 cites W4213151658 @default.
- W2018179601 cites W4237792180 @default.
- W2018179601 cites W4239268488 @default.
- W2018179601 cites W4253384779 @default.
- W2018179601 cites W4294305087 @default.
- W2018179601 doi "https://doi.org/10.1111/j.1572-0241.1999.983_f.x" @default.
- W2018179601 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10201452" @default.
- W2018179601 hasPublicationYear "1999" @default.
- W2018179601 type Work @default.
- W2018179601 sameAs 2018179601 @default.
- W2018179601 citedByCount "473" @default.
- W2018179601 countsByYear W20181796012012 @default.
- W2018179601 countsByYear W20181796012013 @default.
- W2018179601 countsByYear W20181796012014 @default.
- W2018179601 countsByYear W20181796012015 @default.
- W2018179601 countsByYear W20181796012016 @default.
- W2018179601 countsByYear W20181796012017 @default.
- W2018179601 countsByYear W20181796012018 @default.
- W2018179601 countsByYear W20181796012019 @default.
- W2018179601 countsByYear W20181796012020 @default.
- W2018179601 countsByYear W20181796012021 @default.
- W2018179601 countsByYear W20181796012022 @default.
- W2018179601 countsByYear W20181796012023 @default.
- W2018179601 crossrefType "journal-article" @default.
- W2018179601 hasAuthorship W2018179601A5010012768 @default.
- W2018179601 hasAuthorship W2018179601A5029249023 @default.
- W2018179601 hasAuthorship W2018179601A5040611576 @default.
- W2018179601 hasAuthorship W2018179601A5072029105 @default.
- W2018179601 hasAuthorship W2018179601A5072771695 @default.
- W2018179601 hasAuthorship W2018179601A5075116572 @default.
- W2018179601 hasConcept C126322002 @default.
- W2018179601 hasConcept C159654299 @default.
- W2018179601 hasConcept C203014093 @default.
- W2018179601 hasConcept C2779134260 @default.
- W2018179601 hasConcept C2779862289 @default.
- W2018179601 hasConcept C2780349322 @default.
- W2018179601 hasConcept C2781179581 @default.
- W2018179601 hasConcept C2908647359 @default.
- W2018179601 hasConcept C2993432164 @default.
- W2018179601 hasConcept C45189115 @default.
- W2018179601 hasConcept C71924100 @default.
- W2018179601 hasConcept C90924648 @default.
- W2018179601 hasConcept C99454951 @default.
- W2018179601 hasConceptScore W2018179601C126322002 @default.
- W2018179601 hasConceptScore W2018179601C159654299 @default.
- W2018179601 hasConceptScore W2018179601C203014093 @default.
- W2018179601 hasConceptScore W2018179601C2779134260 @default.
- W2018179601 hasConceptScore W2018179601C2779862289 @default.
- W2018179601 hasConceptScore W2018179601C2780349322 @default.
- W2018179601 hasConceptScore W2018179601C2781179581 @default.
- W2018179601 hasConceptScore W2018179601C2908647359 @default.
- W2018179601 hasConceptScore W2018179601C2993432164 @default.
- W2018179601 hasConceptScore W2018179601C45189115 @default.
- W2018179601 hasConceptScore W2018179601C71924100 @default.
- W2018179601 hasConceptScore W2018179601C90924648 @default.
- W2018179601 hasConceptScore W2018179601C99454951 @default.
- W2018179601 hasIssue "4" @default.
- W2018179601 hasLocation W20181796011 @default.
- W2018179601 hasLocation W20181796012 @default.
- W2018179601 hasOpenAccess W2018179601 @default.
- W2018179601 hasPrimaryLocation W20181796011 @default.
- W2018179601 hasRelatedWork W1926879428 @default.
- W2018179601 hasRelatedWork W1993330227 @default.
- W2018179601 hasRelatedWork W2044276960 @default.
- W2018179601 hasRelatedWork W2085571895 @default.
- W2018179601 hasRelatedWork W2170990137 @default.